United Therapeutics (UTHR) Financials: Revenue & Earnings

UTHR price $586.18 -5.02 -0.85%

Ticker
UTHR
Price
$586.18
Change
-5.02 -0.85%
Market cap ?
$25.14B
P/E ?
19.61
Forward P/E ?
22.06
Dividend yield ?
0.00%
Beta ?
0.56
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
54
Value
29
Quality
84
Growth
49

Stocklytics score rationale: value 29, quality 84, growth 49.

Financials

2016201720182019202020212022202320242025
1598800000172530000016278000001448800000148330000016855000001936300000232750000028774000003182700000

United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features several key therapeutics: Remodulin, prescribed for pulmonary arterial…

Fair value

UTHR fair value $721.18. Price $586.18. Price is 19% below fair value.

Below fair value, around its usual discount.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.48B. Growth 19.07%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 42.89M. Net debt -1.52B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Free cash flow adds back growth capex above depreciation.

Compare UTHR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—6.01—781.18M
2026-08-057.276.86783.30M804.65M
2026-05-065.827.00781.50M797.40M
2026-02-257.707.13790.20M813.08M
2025-10-297.166.89799.50M814.80M
2025-07-306.417.29798.60M801.87M
2025-04-306.636.29794.40M778.66M
2025-02-266.196.40735.90M734.73M
2024-10-306.396.43748.90M722.62M
2024-07-315.856.40714.90M691.87M
2024-05-016.175.65677.70M623.97M
2024-02-214.364.19614.70M575.87M
2023-11-015.385.04609.40M587.90M
2023-08-025.244.51596.50M524.17M
2023-05-034.864.52506.90M514.37M
2023-02-222.674.51491.50M519.21M
2022-11-024.913.89516.00M493.21M
2022-08-032.414.13466.90M461.06M
2022-05-045.033.35461.90M420.06M
2022-02-242.353.72415.20M427.59M
2021-11-033.423.59444.70M438.10M
2021-08-043.653.02446.50M446.50M
2021-05-050.612.94379.10M368.31M
2021-02-242.193.14384.90M357.32M
2020-10-283.862.83380.10M280.05M
2020-07-292.412.87362.00M431.10M
2020-04-293.122.75356.30M314.05M
2020-02-261.202.68311.10M694.79M
2019-10-303.162.44401.50M325.47M
2019-07-314.112.49373.60M267.37M
2019-05-013.582.64362.60M89.05M
2019-02-273.342.54381.40M657.14M
2018-10-313.983.49412.70M554.25M
2018-08-013.983.17444.50M354.04M
2018-05-023.764.10389.20M245.96M
2018-02-213.893.77464.70M4.20B
2017-10-256.273.87445.50M274.97M
2017-07-27-1.253.61444.60M1.28B
2017-04-263.893.31370.50M315.26M
2017-02-222.493.61409.00M592.97M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-26ROTHBLATT MARTINE ABuy9.50K$117.761.12M
2026-10-26ROTHBLATT MARTINE ASell600$585.71351.43K
2026-10-26ROTHBLATT MARTINE ASell1.49K$586.54875.12K
2026-10-26ROTHBLATT MARTINE ASell2.71K$587.541.59M
2026-10-26ROTHBLATT MARTINE ASell1.24K$588.47730.29K
2026-10-26ROTHBLATT MARTINE ASell1.28K$589.64754.74K
2026-10-26ROTHBLATT MARTINE ASell680$590.57401.59K
2026-10-26ROTHBLATT MARTINE ASell694$591.60410.57K
2026-10-26ROTHBLATT MARTINE ASell806$592.92477.89K
2026-10-26ROTHBLATT MARTINE ASell9.50K$117.761.12M
2026-10-23ROTHBLATT MARTINE ABuy9.50K$117.761.12M
2026-10-23ROTHBLATT MARTINE ASell200$577.68115.54K
2026-10-23ROTHBLATT MARTINE ASell700$578.80405.16K
2026-10-23ROTHBLATT MARTINE ASell1.04K$579.74601.77K
2026-10-23ROTHBLATT MARTINE ASell1.02K$580.78590.65K
2026-10-23ROTHBLATT MARTINE ASell1.65K$581.82960.01K
2026-10-23ROTHBLATT MARTINE ASell1.73K$582.781.01M
2026-10-23ROTHBLATT MARTINE ASell427$583.83249.30K
2026-10-23ROTHBLATT MARTINE ASell676$584.77395.31K
2026-10-23ROTHBLATT MARTINE ASell778$585.99455.90K
2026-10-23ROTHBLATT MARTINE ASell542$586.93318.11K
2026-10-23ROTHBLATT MARTINE ASell740$588.00435.12K
2026-10-23ROTHBLATT MARTINE ASell9.50K$117.761.12M
2026-10-22ROTHBLATT MARTINE ABuy9.50K$117.761.12M
2026-10-22ROTHBLATT MARTINE ASell74$562.9741.66K
2026-10-22ROTHBLATT MARTINE ASell110$563.9862.04K
2026-10-22ROTHBLATT MARTINE ASell160$565.0990.41K
2026-10-22ROTHBLATT MARTINE ASell160$570.0891.21K
2026-10-22ROTHBLATT MARTINE ASell160$571.7691.48K
2026-10-22ROTHBLATT MARTINE ASell40$573.3922.94K
2026-10-22ROTHBLATT MARTINE ASell130$575.3274.79K
2026-10-22ROTHBLATT MARTINE ASell190$576.80109.59K
2026-10-22ROTHBLATT MARTINE ASell280$577.28161.64K
2026-10-22ROTHBLATT MARTINE ASell160$578.5992.57K
2026-10-22ROTHBLATT MARTINE ASell160$579.6992.75K
2026-10-22ROTHBLATT MARTINE ASell360$581.03209.17K
2026-10-22ROTHBLATT MARTINE ASell400$581.83232.73K
2026-10-22ROTHBLATT MARTINE ASell760$583.09443.15K
2026-10-22ROTHBLATT MARTINE ASell1.20K$584.21701.06K
2026-10-22ROTHBLATT MARTINE ASell1.76K$585.241.03M
2026-10-22ROTHBLATT MARTINE ASell1.28K$586.31750.47K
2026-10-22ROTHBLATT MARTINE ASell937$587.24550.24K
2026-10-22ROTHBLATT MARTINE ASell783$588.19460.55K
2026-10-22ROTHBLATT MARTINE ASell240$589.50141.48K
2026-10-22ROTHBLATT MARTINE ASell160$590.4094.46K
2026-10-22ROTHBLATT MARTINE ASell9.50K$117.761.12M
2026-10-21ROTHBLATT MARTINE ABuy9.50K$117.761.12M
2026-10-21ROTHBLATT MARTINE ASell46$552.5225.42K
2026-10-21ROTHBLATT MARTINE ASell194$553.78107.43K
2026-10-21ROTHBLATT MARTINE ASell550$555.19305.36K
2026-10-21ROTHBLATT MARTINE ASell567$556.41315.49K
2026-10-21ROTHBLATT MARTINE ASell1.70K$557.25948.43K
2026-10-21ROTHBLATT MARTINE ASell1.14K$558.32634.81K
2026-10-21ROTHBLATT MARTINE ASell743$559.25415.52K
2026-10-21ROTHBLATT MARTINE ASell820$560.50459.61K
2026-10-21ROTHBLATT MARTINE ASell200$561.44112.29K
2026-10-21ROTHBLATT MARTINE ASell960$562.54540.04K
2026-10-21ROTHBLATT MARTINE ASell1.25K$563.43705.97K
2026-10-21ROTHBLATT MARTINE ASell768$564.63433.64K
2026-10-21ROTHBLATT MARTINE ASell480$565.36271.37K
2026-10-21ROTHBLATT MARTINE ASell80$566.4345.31K
2026-10-21ROTHBLATT MARTINE ASell9.50K$117.761.12M
2026-10-20ROTHBLATT MARTINE ABuy9.50K$117.761.12M
2026-10-20ROTHBLATT MARTINE ASell117$546.8463.98K
2026-10-20ROTHBLATT MARTINE ASell575$547.79314.98K
2026-10-20ROTHBLATT MARTINE ASell948$548.95520.40K
2026-10-20ROTHBLATT MARTINE ASell586$550.02322.31K
2026-10-20ROTHBLATT MARTINE ASell1.13K$551.03624.87K
2026-10-20ROTHBLATT MARTINE ASell1.56K$551.85860.88K
2026-10-20ROTHBLATT MARTINE ASell240$553.14132.75K
2026-10-20ROTHBLATT MARTINE ASell1.26K$553.97698.00K
2026-10-20ROTHBLATT MARTINE ASell160$555.0988.81K
2026-10-20ROTHBLATT MARTINE ASell440$556.06244.67K
2026-10-20ROTHBLATT MARTINE ASell320$557.12178.28K
2026-10-20ROTHBLATT MARTINE ASell520$558.72290.54K
2026-10-20ROTHBLATT MARTINE ASell280$559.70156.72K
2026-10-20ROTHBLATT MARTINE ASell315$560.67176.61K
2026-10-20ROTHBLATT MARTINE ASell360$561.84202.26K
2026-10-20ROTHBLATT MARTINE ASell464$562.78261.13K
2026-10-20ROTHBLATT MARTINE ASell221$563.56124.55K
2026-10-20ROTHBLATT MARTINE ASell9.50K$117.761.12M
2026-10-19ROTHBLATT MARTINE ABuy9.50K$117.761.12M
2026-10-19ROTHBLATT MARTINE ASell160$534.7585.56K
2026-10-19ROTHBLATT MARTINE ASell360$536.36193.09K
2026-10-19ROTHBLATT MARTINE ASell240$537.11128.91K
2026-10-19ROTHBLATT MARTINE ASell160$538.5486.17K
2026-10-19ROTHBLATT MARTINE ASell880$539.79475.01K
2026-10-19ROTHBLATT MARTINE ASell1.80K$540.63973.13K
2026-10-19ROTHBLATT MARTINE ASell520$541.38281.52K
2026-10-19ROTHBLATT MARTINE ASell260$542.81141.13K
2026-10-19ROTHBLATT MARTINE ASell1.24K$543.73674.23K
2026-10-19ROTHBLATT MARTINE ASell1.04K$544.89566.69K
2026-10-19ROTHBLATT MARTINE ASell1.06K$545.90581.38K
2026-10-19ROTHBLATT MARTINE ASell416$547.00227.55K
2026-10-19ROTHBLATT MARTINE ASell559$547.98306.32K
2026-10-19ROTHBLATT MARTINE ASell360$549.01197.64K
2026-10-19ROTHBLATT MARTINE ASell120$549.6665.96K
2026-10-19ROTHBLATT MARTINE ASell80$551.7744.14K
2026-10-19ROTHBLATT MARTINE ASell40$552.7822.11K
2026-10-19ROTHBLATT MARTINE ASell120$554.0066.48K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 903, holders +5 vs prior quarter. Ownership 98.66%.

HolderSharesChangeChange %Value
BLACKROCK, INC.5.29M-105.12K-1.95%2.87B
AVORO CAPITAL ADVISORS LLC2.78M2.40M+630.99%1.51B
VANGUARD PORTFOLIO MANAGEMENT LLC1.92M-84.31K-4.21%1.04B
VANGUARD CAPITAL MANAGEMENT LLC1.92M-39.28K-2.01%1.04B
STATE STREET CORP1.90M54.10K+2.93%1.03B
RENAISSANCE TECHNOLOGIES LLC1.71M-78.28K-4.38%925.85M
WELLINGTON MANAGEMENT GROUP LLP1.38M-885.22K-39.10%747.20M
GEODE CAPITAL MANAGEMENT, LLC996.60K-236.43K-19.17%538.86M
JUPITER TOPCO LLC831.13K831.13KNew450.14M
NORGES BANK694.75K694.75KNew376.44M
ASSETMARK, INC624.07K8.02K+1.30%338.14M
AQR CAPITAL MANAGEMENT LLC546.00K-280.22K-33.92%294.64M
DIMENSIONAL FUND ADVISORS LP527.90K15.16K+2.96%286.05M
FMR LLC473.41K-54.94K-10.40%256.51M
INVESCO LTD.473.11K-135.26K-22.23%256.34M
BAILLIE GIFFORD & CO467.21K39.08K+9.13%253.15M
DEERFIELD MANAGEMENT COMPANY, L.P.457.00K00.00%247.62M
MORGAN STANLEY436.70K27.41K+6.70%236.62M
VESTAL POINT CAPITAL, LP435.00K360.00K+480.00%235.70M
NORTHERN TRUST CORP430.84K-5.72K-1.31%233.44M
MILLENNIUM MANAGEMENT LLC409.07K336.57K+464.24%221.65M
CAPTION MANAGEMENT, LLC378.20K303.75K+408.03%204.92M
CAPTION MANAGEMENT, LLC366.60K292.15K+392.44%198.63M
FRANKLIN TEMPLETON INC340.27K62.29K+22.41%184.37M
SUSQUEHANNA INTERNATIONAL GROUP, LLP326.30K-30.50K-8.55%176.80M

Earnings and financials

United Therapeutics Corporation (UTHR) trades at $586.18, with a market cap of $25.14B and a trailing P/E of 19.61. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
1598800000172530000016278000001448800000148330000016855000001936300000232750000028774000003182700000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

United Therapeutics (UTHR) Financials: Revenue & Earnings

UTHR$586.18-5.02 -0.85%

$25.14B

Market Cap

19.61

P/E

22.06

Forward P/E

54

Score

Price History